AI English summary of an SEC filing — figures as filed
The company said net sales for Q3 were $4,380 million, compared with $3,946 million a year earlier, a change of 11%, and that underlying sales were 3%. Adjusted earnings per share were $1.43, and GAAP earnings per share were $0.60. The period ended on June 30, 2024.
Key points
AI summaryThe company said net sales for Q3 were $4,380 million, compared with $3,946 million a year earlier, a change of 11%, and that underlying sales were 3%. Adjusted earnings per share were $1.43, and GAAP earnings per share were $0.60. The period ended on June 30, 2024.
Emerson said pretax earnings were $455 million in Q3, down from $822 million a year earlier, and the pretax margin was 10.4%. The company said the $279 million pretax loss on the sale of the Copeland note receivable was recorded in continuing operations but excluded from adjusted earnings per share.
Emerson said operating cash flow in Q3 was $1,067 million, 27% versus $842 million a year earlier, and free cash flow was $975 million, 27% versus $769 million a year earlier.
As of August 2, 2024, the company said it had completed the sale of the Copeland note receivable for pretax cash proceeds of $1.9 billion. It said the sale of the 40% equity stake to Blackstone-managed private equity funds, with pretax cash proceeds of $1.5 billion, is expected to close by the end of August. The company also said it plans to use about $2.9 billion in after-tax cash proceeds from both transactions to pay down existing debt.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Net Sales and Adjusted EPS for Q3 2024
The company said net sales for Q3 were $4,380 million, compared with $3,946 million a year earlier, a change of 11%, and that underlying sales were 3%. Adjusted earnings per share were $1.43, and GAAP earnings per share were $0.60. The period ended on June 30, 2024.
Source · Based on the filing body and exhibits
Emerson Q3 Pretax Earnings and Copeland Note Sale Loss
Emerson said pretax earnings were $455 million in Q3, down from $822 million a year earlier, and the pretax margin was 10.4%. The company said the $279 million pretax loss on the sale of the Copeland note receivable was recorded in continuing operations but excluded from adjusted earnings per share.
Source · Based on the filing body and exhibits
Emerson Q3 Operating and Free Cash Flow
Emerson said operating cash flow in Q3 was $1,067 million, 27% versus $842 million a year earlier, and free cash flow was $975 million, 27% versus $769 million a year earlier.
Source · Based on the filing body and exhibits
Copeland Cash Proceeds and Debt Repayment Plans
As of August 2, 2024, the company said it had completed the sale of the Copeland note receivable for pretax cash proceeds of $1.9 billion. It said the sale of the 40% equity stake to Blackstone-managed private equity funds, with pretax cash proceeds of $1.5 billion, is expected to close by the end of August. The company also said it plans to use about $2.9 billion in after-tax cash proceeds from both transactions to pay down existing debt.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…